Increased Soluble CD155 in the Serum of Cancer Patients

• Akiko Iguchi-Manaka,

  Affiliations Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Genki Okumura,

  Affiliation Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Hiroshi Kojima,

  Affiliations Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Tsukuba, Japan, Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Kasama, Japan

  ⨯
• Yukiko Cho,

  Affiliation Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Kasama, Japan

  ⨯
• Rei Hirochika,

  Affiliation Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Hiroko Bando,

  Affiliation Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Toyomi Sato,

  Affiliation Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Hiroyuki Yoshikawa,

  Current address: Ibaraki Prefectural Central Hospital, Kasama, 309–1793, Japan

  Affiliation Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Hisato Hara,

  Affiliation Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Akira Shibuya,

  Affiliations Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), University of Tsukuba, Tsukuba, Japan, Life Science Center of Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Japan, AMED-CREST, AMED, Japan Agency for Medical Research and Development, Tokyo, Japan

  ⨯
• Kazuko Shibuya

  * E-mail: kazukos@md.tsukuba.ac.jp

  Affiliation Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯